TATX-03
Pre-clinical- Indications
- COVID-19
Company intelligence / Profile preview
ImmunoPrecise Antibodies
Austin, Texas, United Statesipatherapeutics.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Preclinical
01
Overview
ImmunoPrecise Antibodies operates primarily as an AI-driven contract research organization specializing in the discovery and development of therapeutic antibodies. The company’s proprietary platforms—such as B Cell Select®, LENS ai™, and DeepDisplay™—enable rapid identification, engineering, and optimization of novel antibodies across multiple species. While most pipeline assets are developed on behalf of clients or partners, some have advanced into clinical trials through collaborations. Recent highlights include strategic partnerships to develop next-generation ADCs and bispecific antibodies targeting cancer using their patented technologies.
- Therapeutic areas
- OncologyOther
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugateRecombinant proteinNanobody therapyPeptidesSmall molecule
- Industry
- Drug Discovery Services
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Global biotechnology leader ($8–10M partnership for ADC/bispecific development)Vultr & AMD for GPU/AI infrastructureBioNTechInterSystems
Beyond the preview
Go deeper on ImmunoPrecise Antibodies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImmunoPrecise Antibodies.